1346808-98-7 Usage
Uses
Used in Pharmaceutical Synthesis:
Tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine-1-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to facilitate the formation of complex molecular structures and enhance the biological activity of the final product.
Used in Agrochemical Synthesis:
In the agrochemical industry, tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine-1-carboxylate is utilized as a building block for the development of new agrochemicals, contributing to the creation of effective and environmentally friendly products.
Used in Organic Synthesis:
Tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine-1-carboxylate is employed as a versatile reagent in organic synthesis, particularly for the formation of carbon-carbon and carbon-heteroatom bonds, which are crucial for constructing a variety of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1346808-98-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,8,0 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1346808-98:
(9*1)+(8*3)+(7*4)+(6*6)+(5*8)+(4*0)+(3*8)+(2*9)+(1*8)=187
187 % 10 = 7
So 1346808-98-7 is a valid CAS Registry Number.
1346808-98-7Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
, (2013/02/27)
The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase enzymes.
PYRIDINE AND ISOQUINOLINE DERIVATIVES AS SYK- AND JAK-KINASE INHIBITORS
-
Page/Page column 66, (2012/04/17)
The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by inhibition of Syk kinase and/or Janus kinases.
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
-
Paragraph 0183, (2013/03/26)
The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by inhibition of Syk kinase and/or Janus kinases.
